20
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Angiotensin-converting enzyme I/D gene polymorphism and risk of type 2 diabetes mellitus in Iranian individuals

, , , , &
Received 07 Sep 2023, Accepted 05 Apr 2024, Published online: 23 Apr 2024

References

  • Chatterjee, S.; Khunti, K.; Davies, M. J. Type 2 Diabetes. Lancet 2017, 389, 2239–2251. DOI: 10.1016/S0140-6736(17)30058-2.
  • Kavian, Z.; Sargazi, S.; Majidpour, M.; Sarhadi, M.; Saravani, R.; Shahraki, M.; Mirinejad, S.; Heidari Nia, M.; Piri, M. Association of SLC11A1 Polymorphisms with Anthropometric and Biochemical Parameters Describing Type 2 Diabetes Mellitus. Sci. Rep. 2023, 13, 6195. DOI: 10.1038/s41598-023-33239-3.
  • Sargazi, S.; Mollashahi, B.; Sargazi, S.; Heidari Nia, M.; Saravani, R.; Mirinejad, S.; Alidadi, A. Prevalence of miR146a Gene Polymorphisms in Diabetic and Non-Diabetic Patients with Chronic Kidney Disease. Iran. J. Sci. Technol. Trans. Sci. 2022, 46, 21–31. DOI: 10.1007/s40995-021-01229-7.
  • Sargazi, S.; Ravanbakhsh, M.; Nia, M. H.; Mirinejad, S.; Sheervalilou, R.; Majidpour, M.; Danesh, H.; Saravani, R. Association of Polymorphisms within HOX Transcript Antisense RNA (HOTAIR) with Type 2 Diabetes Mellitus and Laboratory Characteristics: A Preliminary Case-Control Study. Dis. Markers. 2022, 2022, 4327311–4327342. DOI: 10.1155/2022/4327342.
  • Isazadeh, A.; Hajazimian, S.; Rahmani, S. A.; Mohammadoo-Khorasani, M.; Samanmanesh, S.; Karimkhanilouei, S. The Effects of Factor II (rs1799963) Polymorphism on Recurrent Pregnancy Loss in Iranian Azeri Women. Riv. Ital. Med. Lab. 2017, 13, 37–40. DOI: 10.1007/s13631-017-0145-y.
  • Ibrahimi, M.; Jamalzei, B.; Akbari, M.; Ibrahimi, R.; Alaei, M.; Moossavi, M.; Mohammadoo-Khorasani, M. Association between Interleukin 4 (IL-4) VNTR, Gene Polymorphism, and Breast Cancer Susceptibility in Iranian Population: Experimental and Web Base Analysis. Bratisl. Lek. Listy. 2018, 119, 651–654. DOI: 10.4149/BLL_2018_116.
  • Mobasheri, L.; Moossavi, S. Z.; Esmaeili, A.; Mohammadoo-Khorasani, M.; Sarab, G. A. Association between Vitamin D Receptor Gene FokI and TaqI Variants with Autism Spectrum Disorder Predisposition in Iranian Population. Gene 2020, 723, 144133. DOI: 10.1016/j.gene.2019.144133.
  • DeFronzo, R. A.; Ferrannini, E.; Groop, L.; Henry, R. R.; Herman, W. H.; Holst, J. J.; Hu, F. B.; Kahn, C. R.; Raz, I.; Shulman, G. I.; et al. Type 2 Diabetes Mellitus. Nat. Rev. Dis. Primers. 2015, 1, 15019. DOI: 10.1038/nrdp.2015.19.
  • Breton, M.-C.; Guénette, L.; Amiche, M. A.; Kayibanda, J.-F.; Grégoire, J.-P.; Moisan, J. Burden of Diabetes on the Ability to Work: A Systematic Review. Diabetes Care. 2013, 36, 740–749. DOI: 10.2337/dc12-0354.
  • Olokoba, A. B.; Obateru, O. A.; Olokoba, L. B. Type 2 Diabetes Mellitus: A Review of Current Trends. Oman Med. J. 2012, 27, 269–273. PMID: 23071876. DOI: 10.5001/omj.2012.68.
  • Fletcher, B.; Gulanick, M.; Lamendola, C. Risk Factors for Type 2 Diabetes Mellitus. J. Cardiovasc. Nurs. 2002, 16, 17–23. DOI: 10.1097/00005082-200201000-00003.
  • Wilcox, G. Insulin and Insulin Resistance. Clin. Biochem. Rev. 2005, 26, 19–39.
  • Woodman, R. J.; Mori, T. A.; Burke, V.; Puddey, I. B.; Watts, G. F.; Beilin, L. J. Effects of Purified Eicosapentaenoic and Docosahexaenoic Acids on Glycemic Control, Blood Pressure, and Serum Lipids in Type 2 Diabetic Patients with Treated Hypertension. Am. J. Clin. Nutr. 2002, 76, 1007–1015. DOI: 10.1093/ajcn/76.5.1007.
  • Cordonnier, D. J.; Zaoui, P.; Halimi, S. Role of ACE Inhibitors in Patients with Diabetes Mellitus. Drugs 2001, 61, 1883–1892. DOI: 10.2165/00003495-200161130-00001.
  • Hsueh, W. A.; Wyne, K. Renin‐Angiotensin‐Aldosterone System in Diabetes and Hypertension. J. Clin. Hypertens. (Greenwich) 2011, 13, 224–237. DOI: 10.1111/j.1751-7176.2011.00449.x.
  • Sayed-Tabatabaei, F.; Oostra, B.; Isaacs, A.; Van Duijn, C.; Witteman, J. ACE Polymorphisms. Circ. Res. 2006, 98, 1123–1133. DOI: 10.1161/01.RES.0000223145.74217.e7.
  • Rigat, B.; Hubert, C.; Alhenc-Gelas, F.; Cambien, F.; Corvol, P.; Soubrier, F. An Insertion/Deletion Polymorphism in the Angiotensin I-Converting Enzyme Gene Accounting for Half the Variance of Serum Enzyme Levels. J. Clin. Invest. 1990, 86, 1343–1346. DOI: 10.1172/JCI114844.
  • Stephens, J. W.; Dhamrait, S. S.; Cooper, J. A.; Acharya, J.; Miller, G. J.; Hurel, S. J.; Humphries, S. E. The D Allele of the ACE I/D Common Gene Variant Is Associated with Type 2 Diabetes Mellitus in Caucasian Subjects. Mol. Genet. Metab. 2005, 84, 83–89. DOI: 10.1016/j.ymgme.2004.09.002.
  • Rakhshani Nejad, A.; Sargazi, S.; Ghasemi, M.; Samareh Moosavi, S.; Heidari Nia, M.; Saravani, R. Association Study to Evaluate Foxo1 and Foxo3 Gene Polymorphisms in Polycystic Ovary Syndrome: A Preliminary Case–Control Study and In silico Analysis. Mol. Biol. Rep. 2023, 50, 3569–3580. DOI: 10.1007/s11033-023-08292-w.
  • Salimi, S.; Sargazi, S.; Mollashahi, B.; Heidari Nia, M.; Mirinejad, S.; Majidpour, M.; Ghasemi, M.; Sargazi, S. Association of Polymorphisms in miR146a, an Inflammation-Associated MicroRNA, with the Risk of Idiopathic Recurrent Spontaneous Miscarriage: A Case-Control Study. Dis. Markers. 2022, 2022, 1495010–1495082. DOI: 10.1155/2022/1495082.
  • Sadeghi, M. B.; Nakhaee, A.; Saravani, R.; Sargazi, S. Significant Association of LXRβ (NR1H2) Polymorphisms (rs28514894, rs2303044) with Type 2 Diabetes Mellitus and Laboratory Characteristics. J. Diabetes Metab. Disord. 2021, 20, 261–270. DOI: 10.1007/s40200-021-00740-3.
  • Martorell-Marugan, J.; Toro-Dominguez, D.; Alarcon-Riquelme, M. E.; Carmona-Saez, P. MetaGenyo: A Web Tool for Meta-Analysis of Genetic Association Studies. BMC Bioinformatics. 2017, 18, 563. DOI: 10.1186/s12859-017-1990-4.
  • Taha, M. M.; Mahdy-Abdallah, H.; Shahy, E. M.; Helmy, M. A.; ElLaithy, L. S. Diagnostic Efficacy of Cystatin-C in Association with Different ACE Genes Predicting Renal Insufficiency in T2DM. Sci. Rep. 2023, 13, 5288. DOI: 10.1038/s41598-023-32012-w.
  • Ud Din, U. A.; Khan, W. A.; Shahzad, K.; Ali, B.; Hussain, M.; Awan, F. R. Genetic Polymorphism of ACE (I/D) Is Associated with Diabetic Nephropathy in Pakistani Subjects. Pakistan Journal of Zoology 2023, 55, 1537.
  • El Sayed, A. M.; Ibrahim, W. M.; El Badawy, A. M.; El Araby, M. M.; Abd Elmoniem, R. O. Angiotensin Converting Enzyme Insertion/Deletion Gene Polymorphism in Egyptian Population with Type 2 Diabetes and Its Relation to Diabetic Nephropathy. The Egyptian Journal of Hospital Medicine 2023, 91, 4505–4510. DOI: 10.21608/ejhm.2023.296754.
  • Larejani, B.; Zahedi, F. Epidemiology of Diabetes Mellitus in Iran. Iranian Journal of Diabetes and Metabolism 2001, 1, 1–8.
  • Romao, I.; Roth, J. Genetic and Environmental Interactions in Obesity and Type 2 Diabetes. J. Am. Diet. Assoc. 2008, 108, S24–S28. DOI: 10.1016/j.jada.2008.01.022.
  • Murea, M.; Ma, L.; Freedman, B. I. Genetic and Environmental Factors Associated with Type 2 Diabetes and Diabetic Vascular Complications. Rev. Diabet. Stud. 2012, 9, 6–22. DOI: 10.1900/RDS.2012.9.6.
  • Masuyer, G.; Yates, C. J.; Sturrock, E. D.; Acharya, K. R. Angiotensin-I Converting Enzyme (ACE): Structure, Biological Roles, and Molecular Basis for Chloride Ion Dependence. Biol. Chem. 2014, 395, 1135–1149. DOI: 10.1515/hsz-2014-0157.
  • Yates, C. J.; Masuyer, G.; Schwager, S. L.; Akif, M.; Sturrock, E. D.; Acharya, K. R. Molecular and Thermodynamic Mechanisms of the Chloride-Dependent Human angiotensin-I-Converting Enzyme (ACE). J. Biol. Chem. 2014, 289, 1798–1814. DOI: 10.1074/jbc.M113.512335.
  • Unger, T. The Role of the Renin-Angiotensin System in the Development of Cardiovascular Disease. Am. J. Cardiol. 2002, 89, 3A–9A; discussion 10A. DOI: 10.1016/s0002-9149(01)02321-9.
  • Jayapalan, J. J.; Muniandy, S.; Chan, S. P. Null Association between ACE Gene I/D Polymorphism and Diabetic Nephropathy among Multiethnic Malaysian Subjects. Indian J. Hum. Genet. 2010, 16, 78–86. DOI: 10.4103/0971-6866.69351.
  • Tiret, L.; Rigat, B.; Visvikis, S.; Breda, C.; Corvol, P.; Cambien, F.; Soubrier, F. Evidence, from Combined Segregation and Linkage Analysis, That a Variant of the Angiotensin I-Converting Enzyme (ACE) Gene Controls Plasma ACE Levels. Am. J. Hum. Genet. 1992, 51, 197–205.
  • Yoshida, H.; Kuriyama, S.; Atsumi, Y.; Tomonari, H.; Mitarai, T.; Hamaguchi, A.; Kubo, H.; Kawaguchi, Y.; Kon, V.; Matsuoka, K.; et al. Angiotensin I Converting Enzyme Gene Polymorphism in Non-Insulin Dependent Diabetes Mellitus. Kidney Int. 1996, 50, 657–664. DOI: 10.1038/ki.1996.362.
  • Fava, S.; Azzopardi, J.; Ellard, S.; Hattersley, A. T. ACE Gene Polymorphism as a Prognostic Indicator in Patients with Type 2 Diabetes and Established Renal Disease. Diabetes Care. 2001, 24, 2115–2120. DOI: 10.2337/diacare.24.12.2115.
  • Dudley, C. R.; Keavney, B.; Stratton, I. M.; Turner, R. C.; Ratcliffe, P. J. UK Prospective Diabetes Study XV: Relationship of Renin-Angiotensin System Gene Polymorphisms with Microalbuminuria in NIDDM. Kidney Int. 1995, 48, 1907–1911. DOI: 10.1038/ki.1995.490.
  • Felehgari, V.; Rahimi, Z.; Mozafari, H.; Vaisi-Raygani, A. ACE Gene Polymorphism and Serum ACE Activity in Iranians Type II Diabetic Patients with Macroalbuminuria. Mol. Cell. Biochem. 2011, 346, 23–30. DOI: 10.1007/s11010-010-0587-2.
  • Nikzamir, A.; Rashidi, A.; Esteghamati, A.; Nakhjavani, M.; Golmohammadi, T.; Khalilzadeh, O. The Relationship between ACE Gene Insertion/Deletion Polymorphism and Diabetic Retinopathy in Iranian Patients with Type 2 Diabetes. Ophthalmic Genet. 2010, 31, 108–113. DOI: 10.3109/13816810.2010.482554.
  • Sikdar, M.; Purkait, P.; Raychoudhury, P.; Bhattacharya, S.; Naidu, J.; Sarkar, B. ACE Gene Insertion/Deletion Polymorphism and Type-2 Diabetic Nephropathy in Eastern Indian Population. Human Biology Review 2013, 2, 66–76.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.